ALEC

Alector, Inc. Common Stock

$1.88

Current Price

All

AI analysis

Read what the AI thinks of Alector, Inc. Common Stock in the app.

Analyses are generated by AI from public data and are not investment advice.

Get the app

Key figures

Dividend per share

—

Yield

—

EPS

-$1.09

P/E

—

Data as of Oct 8

Why it matters for the long term

Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.

Upcoming events

Quarterly earnings

Expected EPS: -$0.25

Nov 10

Posts

No posts about ALEC yet.

About Alector, Inc. Common Stock

Alector is a clinical-stage biotechnology company based in the US. It develops experimental antibody drugs aimed at brain diseases such as Alzheimer's and other forms of dementia. It has no approved product to sell, so its small revenue comes from research partnerships and collaboration payments from larger drug companies.